ARC, the innovation arm of Sheba Medical Center Israel’s largest hospital and a global leader in clinical trials, announced today a collaboration with Roche, a leading provider of digital pathology solutions worldwide, to help improve the diagnosis and treatment of non-small cell lung cancer.
An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging an attack from natural killer cells in an animal model, a study led by UT Southwestern Medical Center researchers shows. The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to new types of immunotherapy that rely on this novel strategy.
